TP53 and breast carcinoma: observed that PITX1 could directly bind to the promoter of p53, thereby transcribing and activating p53 in breast cancer cells, which in turn activates DNA damage, oncogene activation, hypoxia, nutrient deficiency, and other stress-related signaling pathways (23).